Jody A. Charnow

Chronic kidney disease is 3 times more likely to develop among individuals with vs without gout, according to a large retrospective cohort study.

Gout may be a risk factor for the development of CKD stage ≥3.

An expert panel evaluated 23 separate statements related to the etiology, diagnosis, and treatment of gout.

Study reveals an 11% prevalence of active gout among solid organ transplant recipients overall and a 13% prevalence among kidney transplant recipients.

In a British study, nurse-led care emphasizing patient education and engagement significantly improved the proportion of gout sufferers who achieved target serum urate levels.

Inhibition of IL-1ß with canakinumab significantly decreased gout attack risk at all baseline serum uric acid (SUA) levels and without changing SUA levels.